日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Evaluating teratoma formation risk of pluripotent stem cell-derived cell therapy products: a consensus recommendation from the Health and Environmental Sciences Institute's International Cell Therapy Committee

评估多能干细胞衍生细胞治疗产品畸胎瘤形成风险:健康与环境科学研究所国际细胞治疗委员会的共识建议

Watanabe, Takeshi; La Shu, Shin; Rio-Espinola, Alberto Del; Ferreira, Joana Rita; Bando, Kiyoko; Lemmens, Myriam; Pande, Parimal; de Wolf, Charlotte; Chen, Connie L; Elke, Ericson; Rao, Gautham K; van den Hoorn, Tineke; Mouriès, Lucilia Pereira; Myers, Meagan B; Yasuda, Satoshi

Transferability, Reproducibility and Sensitivity of Mutation Quantification by Duplex Sequencing

双链测序法突变定量的可转移性、可重复性和灵敏度

Zhang, Shaofei; Parsons, Barbara L; Fitzgerald, Devon; Ashford, Anne; Auman, James Todd; Chen, Tao; Dodge, Annette; Elhajouji, Azeddine; Pfaller, Lena; Harris, Shawn; Higgins, Jake; Hobbs, Cheryl A; Marchetti, Francesco; Meier, Matthew J; Myers, Meagan B; Salk, Jesse; Sahroui, Rebecca; Schuster, David; Settivari, Raja; Smith-Roe, Stephanie L; Yauk, Carole L; Yan, Jian; Williams, Andrew; Chen, Connie L

Severity of effect considerations regarding the use of mutation as a toxicological endpoint for risk assessment: A report from the 8th International Workshop on Genotoxicity Testing (IWGT)

关于将突变作为风险评估毒理学终点时效应严重性的考虑:第八届国际遗传毒性测试研讨会(IWGT)报告

Parsons, Barbara L; Beal, Marc A; Dearfield, Kerry L; Douglas, George R; Gi, Min; Gollapudi, B Bhaskar; Heflich, Robert H; Horibata, Katsuyoshi; Kenyon, Michelle; Long, Alexandra S; Lovell, David P; Lynch, Anthony M; Myers, Meagan B; Pfuhler, Stefan; Vespa, Alisa; Zeller, Andreas; Johnson, George E; White, Paul A

The Pan-RAF-MEK Nondegrading Molecular Glue NST-628 Is a Potent and Brain-Penetrant Inhibitor of the RAS-MAPK Pathway with Activity across Diverse RAS- and RAF-Driven Cancers

泛 RAF-MEK 非降解分子胶 NST-628 是一种强效的脑渗透性 RAS-MAPK 通路抑制剂,可有效治疗多种 RAS 和 RAF 驱动的癌症

Meagan B Ryan #, Bradley Quade #, Natasha Schenk, Zhong Fang, Marshall Zingg, Steven E Cohen, Brooke M Swalm, Chun Li, Ayşegül Özen, Chaoyang Ye, Maria Stella Ritorto, Xin Huang, Arvin C Dar, Yongxin Han, Klaus P Hoeflich, Michael Hale, Margit Hagel

Accelerated Nanocomposite Hydrogel Gelation Times Independent of Gold Nanoparticle Ligand Functionality

加速纳米复合水凝胶凝胶化时间与金纳米颗粒配体功能无关

Couturier, Brianna; Kozak, Gloria; Levering, John; Zini, Anna; Elinski, Meagan B

CarcSeq detection of lorcaserin-induced clonal expansion of Pik3ca H1047R mutants in rat mammary tissue

利用CarcSeq技术检测氯卡色林诱导的大鼠乳腺组织中Pik3ca H1047R突变体的克隆扩增

Jennifer B Faske ,Meagan B Myers ,Matthew Bryant ,Xiaobo He ,Florence McLellen ,Todd Bourcier ,Barbara L Parsons

865. Same Shift Susceptibility Testing of Cefepime-Taniborbactam and Cefiderocol Using The Selux Next-Generation Phenotyping System

865. 使用Selux下一代表型系统对头孢吡肟-他尼博巴坦和头孢地洛进行同向药敏试验

Myers, Meagan B; Valdivieso-Martínez, Bernardo; Sauri, Inma; Philibert, Juliette; Calderon, Jose Miguel; Gas, María-Eugenia; Diaz, Javier; López-Hontangas, Jose Luis; Navarro, David; Forner, Maria Jose; Redon, Josep; Jimenez, David; Baker, Kristin; Spears, Benjamin; Flentie, Kelly; Roberts, Kristen; Michaels, Gabriel; Stern, Eric

Chromatin-bound RB targets promoters, enhancers, and CTCF-bound loci and is redistributed by cell-cycle progression

染色质结合的 RB 靶向启动子、增强子和 CTCF 结合位点,并根据细胞周期进程重新分布

Ioannis Sanidas, Hanjun Lee, Purva H Rumde, Gaylor Boulay, Robert Morris, Gabriel Golczer, Marcelo Stanzione, Soroush Hajizadeh, Jun Zhong, Meagan B Ryan, Ryan B Corcoran, Benjamin J Drapkin, Miguel N Rivera, Nicholas J Dyson, Michael S Lawrence

KRASG12C-independent feedback activation of wild-type RAS constrains KRASG12C inhibitor efficacy

KRASG12C 独立的野生型 RAS 反馈激活限制了 KRASG12C 抑制剂的功效

Meagan B Ryan, Oluwadara Coker, Alexey Sorokin, Katerina Fella, Haley Barnes, Edmond Wong, Preeti Kanikarla, Fengqin Gao, Youyan Zhang, Lian Zhou, Scott Kopetz, Ryan B Corcoran

Clinical Acquired Resistance to KRASG12C Inhibition through a Novel KRAS Switch-II Pocket Mutation and Polyclonal Alterations Converging on RAS-MAPK Reactivation

通过新型 KRAS Switch-II 口袋突变和多克隆变异(以 RAS-MAPK 再激活为中心)获得对 KRASG12C 抑制的临床获得性耐药性

Noritaka Tanaka #, Jessica J Lin #, Chendi Li #, Meagan B Ryan, Junbing Zhang, Lesli A Kiedrowski, Alexa G Michel, Mohammed U Syed, Katerina A Fella, Mustafa Sakhi, Islam Baiev, Dejan Juric, Justin F Gainor, Samuel J Klempner, Jochen K Lennerz, Giulia Siravegna, Liron Bar-Peled, Aaron N Hata, Rebecc